Not applicableStudy completedNCT01189123What this trial is testingCell Mediated Immunity in Older AdultsWho this might be right forImmunity to Influenza Vaccine Vanderbilt University 105
Early research (Phase 1)Study completedNCT03581903What this trial is testingA Study in Healthy Adults to Assess Priming With Antigenically Mismatched Live Attenuated A/H7N3 Influenza Virus Vaccine Followed by Inactivated A/H7N9 Influenza Virus VaccineWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 20
Not applicableStudy completedNCT06972810What this trial is testingHuman Infection Study of H3N2 Influenza in Healthy AdultsWho this might be right forInfluenza University of Melbourne 11
Post-approval studies (Phase 4)Study completedNCT01811823What this trial is testingEffect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in AdultsWho this might be right forInfluenzaHIVTuberculosis University of Witwatersrand, South Africa 301
Large-scale testing (Phase 3)Looking for participantsNCT06573008What this trial is testingStudy of GP681 Tablets Compared With Placebo in Patients With Influenza at High Risk of Influenza ComplicationsWho this might be right forInfluenza, Human Jiangxi Qingfeng Pharmaceutical Co. Ltd. 328
Post-approval studies (Phase 4)Study completedNCT03502291What this trial is testingThe Effect of Live Attenuated Inactivated Influenza Vaccine on Experimental Human Pneumococcal Carriage StudyWho this might be right forPneumoniaInfluenza, Human Liverpool University Hospitals NHS Foundation Trust 324
Not applicableStudy completedNCT01106196What this trial is testingThe Role of Influenza as a Trigger for Acute Myocardial Infarction: a CALIBER StudyWho this might be right forMyocardial InfarctionInfluenza University College, London 11,208
Testing effectiveness (Phase 2)Ended earlyNCT01003418What this trial is testingStudy to Evaluate Safety and Immunogenicity of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in ChildrenWho this might be right forInfluenza GlaxoSmithKline 8
Large-scale testing (Phase 3)Study completedNCT01527110What this trial is testingIntravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza InfectionWho this might be right forInfluenza, Human GlaxoSmithKline 21
Post-approval studies (Phase 4)Study completedNCT02640989What this trial is testingSafety and Immunogenicity of Three Seasonal Trivalent Influenza Vaccines in China MilitaryWho this might be right forInfluenza Center for Disease Prevention and Control of Beijing Military Region 292
Large-scale testing (Phase 3)Study completedNCT03932682What this trial is testingEfficacy Study With QIVc in Pediatric SubjectsWho this might be right forInfluenza, Human Seqirus 5,723
Early research (Phase 1)Study completedNCT02544880What this trial is testingPDE5 Inhibition Via Tadalafil to Enhance Anti-Tumor Mucin 1 (MUC1) Vaccine Efficacy in Patients With HNSCCWho this might be right forHead and Neck Squamous Cell CarcinomaHead and Neck Cancer Donald T. Weed, MD, FACS 16
Post-approval studies (Phase 4)Study completedNCT00137579What this trial is testingSafety of the Intramuscular Route of the Anti-Flu Vaccine in Patients Receiving Oral Anticoagulation TherapyWho this might be right forInfluenza Catalan Institute of Health 216
Large-scale testing (Phase 3)Study completedNCT05559476What this trial is testingA Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 65 Years and AboveWho this might be right forRespiratory Syncytial Virus Infections GlaxoSmithKline 1,029
Testing effectiveness (Phase 2)UnknownNCT01055990What this trial is testingBasic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 PatientsWho this might be right forVirus DiseasesRespiratory Tract DiseasesRespiratory Tract Infections+2 more Shanghai Public Health Clinical Center 7
Testing effectiveness (Phase 2)Study completedNCT03883113What this trial is testingEfficacy of MVA-NP+M1 in the Influenza H3N2 Human Challenge ModelWho this might be right forInfluenza Barinthus Biotherapeutics 145
Early research (Phase 1)Study completedNCT05126979What this trial is testingThe Objectives of This Study Are Study of the Reactogenicity, Safety and Immunogenicity of Flu-M Inactivated Split Influenza Vaccine in Volunteers Aged 18-60 YearsWho this might be right forInfluenza St. Petersburg Research Institute of Vaccines and Sera 45
Post-approval studies (Phase 4)Study completedNCT06024096What this trial is testingSystems Biological Assessment of Statin Effect on Vaccine ResponsesWho this might be right forVaccine Response Emory University 63
Testing effectiveness (Phase 2)Study completedNCT00230750What this trial is testingInactivated Influenza A/H5N1 Vaccine in the ElderlyWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 261
Very early researchStudy completedNCT05148780What this trial is testingAcute Respiratory Infections in Global Outpatient SettingWho this might be right forAcute Respiratory Infection Janssen Research & Development, LLC 245